ATTD 2021: Despite High Upfront Cost, Medtronic’s 780G Could Offer Cost Savings
In a talk at the 2021 Advanced Technologies & Treatments for Diabetes conference, Medtronic's European director of medical affairs explained how its MiniMed 780G insulin pump can reduce long-term treatment costs for diabetics.
You may also be interested in...
Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills, New SaMD Cybersecurity Standards
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.
To increase its diabetes care products market share, Medtronic has obtained CE marks for a new continuous glucose monitor and a smart insulin pen.
In an interview, Elgar Fleisch, co-author of The Digital Pill, proselytized the benefits of digital health, explaining how particular innovations could solve problems in health care.